Systematic review: the impact of gastro-oesophageal reflux disease on work productivity
- PMID: 16842452
- DOI: 10.1111/j.1365-2036.2006.02996.x
Systematic review: the impact of gastro-oesophageal reflux disease on work productivity
Abstract
Background: Gastro-oesophageal reflux disease has wide-ranging effects on patients' lives.
Aim: To review systematically the effects of gastro-oesophageal reflux disease on work productivity.
Methods: Studies of gastro-oesophageal reflux disease and work productivity were identified in a systematic literature search and their results were valued in US dollars using the human capital method. Work productivity loss was defined as absence from work (absenteeism) plus reduced effectiveness while working (presenteeism).
Results: Eight eligible studies were included. Reported work productivity loss among individuals with gastro-oesophageal reflux disease ranged from 6% to 42% and was primarily because of presenteeism (6-40%) rather than absenteeism (<1% to 7%). Reported losses were greatest in patients experiencing sleep disturbance because of gastro-oesophageal reflux disease, and lowest in individuals from the general population taking appropriate prescription medication. Work productivity impairment correlated with symptom severity and responded to acid-suppressive therapy. Assuming a 40-h working week and average wages in the US, the weekly mean productivity loss per employee with gastro-oesophageal reflux disease can be estimated between 2.4 (62 dollars) and 16.6 h (430 dollars), depending on the population studied.
Conclusions: Gastro-oesophageal reflux disease has a substantial impact on employee productivity, primarily by impairing productivity while working. Further studies are needed to confirm that this impact can be decreased by acid-suppressive therapy.
Similar articles
-
Cisapride treatment for gastro-oesophageal reflux in children.Cochrane Database Syst Rev. 2003;(4):CD002300. doi: 10.1002/14651858.CD002300. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD002300. doi: 10.1002/14651858.CD002300.pub2. PMID: 14583950 Updated.
-
Cisapride treatment for gastro-oesophageal reflux in children.Cochrane Database Syst Rev. 2002;(3):CD002300. doi: 10.1002/14651858.CD002300. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2003;(4):CD002300. doi: 10.1002/14651858.CD002300. PMID: 12137654 Updated.
-
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004823. doi: 10.1002/14651858.CD004823.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004823. doi: 10.1002/14651858.CD004823.pub3. PMID: 15846735 Updated.
-
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004823. doi: 10.1002/14651858.CD004823.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD004823. doi: 10.1002/14651858.CD004823.pub4. PMID: 17054216 Updated.
-
The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.Aliment Pharmacol Ther. 2002 Feb;16(2):261-73. doi: 10.1046/j.1365-2036.2002.01167.x. Aliment Pharmacol Ther. 2002. PMID: 11860409
Cited by
-
Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany.Eur J Med Res. 2010 Mar 30;15(3):124-30. doi: 10.1186/2047-783x-15-3-124. Eur J Med Res. 2010. PMID: 20452898 Free PMC article. Clinical Trial.
-
Effect of Dewaxed Coffee on Gastroesophageal Symptoms in Patients with GERD: A Randomized Pilot Study.Nutrients. 2022 Jun 16;14(12):2510. doi: 10.3390/nu14122510. Nutrients. 2022. PMID: 35745239 Free PMC article. Clinical Trial.
-
On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter Study.J Neurogastroenterol Motil. 2023 Oct 30;29(4):460-469. doi: 10.5056/jnm23130. J Neurogastroenterol Motil. 2023. PMID: 37814436 Free PMC article.
-
Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease.World J Gastroenterol. 2018 Jun 7;24(21):2291-2299. doi: 10.3748/wjg.v24.i21.2291. World J Gastroenterol. 2018. PMID: 29881238 Free PMC article. Clinical Trial.
-
Esophageal malignancy: a growing concern.World J Gastroenterol. 2012 Dec 7;18(45):6521-6. doi: 10.3748/wjg.v18.i45.6521. World J Gastroenterol. 2012. PMID: 23236223 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical